Literature DB >> 23111802

Familial Mediterranean fever in Japan.

Kiyoshi Migita1, Ritei Uehara, Yoshikazu Nakamura, Michio Yasunami, Ayako Tsuchiya-Suzuki, Masahide Yazaki, Akinori Nakamura, Junya Masumoto, Akihiro Yachie, Hiroshi Furukawa, Hiromi Ishibashi, Hiroaki Ida, Kazuko Yamazaki, Atsushi Kawakami, Kazunaga Agematsu.   

Abstract

Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that is prevalent in Mediterranean populations. While it is considered a rare disease in the rest of world, a significant number of FMF patients have been reported in East Asia, including Japan. Our aim was to determine the prevalence of FMF in Japan and elucidate the clinical and genetic features of Japanese patients. A primary nationwide survey of FMF was conducted between January and December 2009. Hospitals specializing in pediatrics and hospitals with pediatric, internal medicine, and rheumatology/allergy departments were asked to report all patients with FMF during the survey year. The estimated total number of Japanese FMF patients was 292 (95% confidence interval, 187-398 people). We evaluated the clinical and genetic profiles of Japanese patients from the data obtained in a secondary survey of 134 FMF patients. High-grade fever was observed in 95.5%, chest pain (pleuritis symptoms) in 36.9%, abdominal pain (peritonitis symptoms) in 62.7%, and arthritis in 31.3%. Of the patients profiled, 25.4% of patients experienced their first attack before 10 years of age, 37.3% in their teens, and 37.3% after age 20 years. Colchicine was effective in 91.8% of patients at a relatively low dose (mean dose, 0.89 ± 0.45 mg/d). AA amyloidosis was confirmed in 5 patients (3.7%). Of the 126 patients studied, 109 (86.5%) were positive for 1 or more genetic mutations and 17 (13.5%) had no mutation detected. Common Mediterranean fever gene (MEFV) mutations were E148Q/M694I (19.8%) and M694I/normal (12.7%). The differences in the prevalence of peritonitis, pleuritis, and a family history of FMF were statistically significant between FMF patients with MEFV exon 10 mutations compared with those without exon 10 mutations.In conclusion, a significant number of patients with FMF exist in Japan. Although Japanese patients with FMF are clinically or genetically different from Mediterranean patients, the delay in diagnosis is an issue that should be resolved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23111802     DOI: 10.1097/MD.0b013e318277cf75

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  30 in total

1.  Familial Mediterranean Fever developing in a Japanese kidney transplant recipient.

Authors:  Masahiko Yazawa; Makoto Tsujita; Norihiko Goto; Takayuki Yamamoto; Takahisa Hiramitsu; Satoshi Ashimine; Koji Nanmoku; Shunji Narumi; Yoshihiro Tominaga; Yoshihiko Watarai
Journal:  CEN Case Rep       Date:  2015-07-20

Review 2.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

3.  Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations.

Authors:  Rino Sugiyama; Kazunaga Agematsu; Kiyoshi Migita; Jun Nakayama; Sho Mokuda; Fumiya Ogura; Kaho Haraikawa; Chikara Okumura; Satomi Suehiro; Shinnosuke Morikawa; Yuki Ito; Junya Masumoto
Journal:  Mol Biol Rep       Date:  2013-12-07       Impact factor: 2.316

Review 4.  Clinical perspectives and therapeutic strategies: pediatric autoinflammatory disease-a multi-faceted approach to fever of unknown origin of childhood.

Authors:  Akihiro Yachie
Journal:  Inflamm Regen       Date:  2022-07-02

Review 5.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Xi Yin; Fangyuan Tian; Bin Wu; Ting Xu
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

6.  CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.

Authors:  Junichi Watanabe; Ken Sato; Yukiko Osawa; Toshikatsu Horiuchi; Shoichiro Kato; Reina Hikota-Saga; Takaaki Maekawa; Takeshi Yamamura; Ayako Kobayashi; Shinichi Kobayashi; Fumihiko Kimura
Journal:  Int J Hematol       Date:  2018-03-29       Impact factor: 2.490

7.  The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.

Authors:  Yumi Tani; Takayuki Kishi; Takako Miyamae; Manabu Kawamoto; Yasushi Kawaguchi; Atsuo Taniguchi; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2020-01-02       Impact factor: 2.980

Review 8.  A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin.

Authors:  Seza Ozen; Yelda Bilginer
Journal:  Nat Rev Rheumatol       Date:  2013-11-19       Impact factor: 20.543

9.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Bin Wu; Ting Xu; Youping Li; Xi Yin
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19

10.  One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study.

Authors:  Dai Kishida; Masahide Yazaki; Akinori Nakamura; Fumio Nomura; Takeshi Kondo; Takanori Uehara; Masatomi Ikusaka; Akira Ohya; Norihiko Watanabe; Ryuta Endo; Satoshi Kawaai; Yasuhiro Shimojima; Yoshiki Sekijima
Journal:  Rheumatol Int       Date:  2017-11-18       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.